Technology | Mammography | April 05, 2017

FDA Approves High Definition Breast Tomosynthesis from Siemens Healthineers

New EMPIRE technology applies iterative and machine learning algorithms that provide a clearer, more concise 3-D breast reconstruction on Siemens’ Mammomat Inspiration digital mammography system

Siemens Healthineers, High Definition Breast Tomosynthesis, FDA approval, Mammomat Inspiration, DBT, mammography, SBI, RSNA 2017

April 5, 2017 — Siemens Healthineers announced that the U.S. Food and Drug Administration (FDA) has approved High Definition Breast Tomosynthesis. This unique form of digital breast tomosynthesis (DBT) includes new algorithms designed to deliver a heightened level of sensitivity to breast cancer detection and diagnosis over 2-D mammography alone. 

High Definition Breast Tomosynthesis builds on the established DBT platform from Siemens Healthineers with what the company calls the industry’s widest tomo sweep of 50 degrees. Siemens also said it delivers images of exceptional clarity, and is the first solution approved for 3-D-only mammograms. 

High Definition Breast Tomosynthesis incorporates new EMPIRE (Enhanced Multiple Parameter Iterative Reconstruction) technology, a combination of iterative and machine learning algorithms that provide a clearer, more concise 3-D reconstruction.

While EMPIRE technology has been approved as a 3-D-only exam, it also includes Insight 2-D and 3-D — what Siemens calls the industry’s first synthetic software-generated visualization of tomosynthesis volumes in both 2-D and 3-D. Insight 2-D allows breast imagers to obtain a 2-D image from the EMPIRE 3-D image set, providing them with a navigational support tool to their 3-D-only exams without subjecting patients to added dose. Insight 3-D adds new depth to the visualization of the breast anatomy.

High Definition Breast Tomosynthesis is available as an option on the company’s Mammomat Inspiration with Tomosynthesis Option digital mammography system.

For more information: www.usa.healthcare.siemens.com

Related Content

SmartCurve technology, a revolutionary breast imaging technology designed specifically for the curvature of the female breast to provide every woman with a more comfortable and accurate mammogram.
News | Mammography | September 14, 2018
Solis Mammography declared September Breast Wellness Month a
breast screening
News | Clinical Trials | September 13, 2018
Fewer and fewer women die from breast cancer in recent years but, surprisingly, the decline is just as large in the a
Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
Feature | Breast Imaging | September 07, 2018 | By JoAnn Pushkin
If you are confused about the conflicting advice surrounding mammography screening guidelines, welcome to the club.

Image courtesy of Philips Healthcare

Feature | Magnetic Resonance Imaging (MRI) | September 06, 2018 | By Melinda Taschetta-Millane
According to the Prescient & Strategic Intelligence report, “Global Magnetic Resonance Imaging (MRI) Market Size,...
Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...